SRSF3 and hepatocellular carcinoma: Wang et al. demonstrated that serine- and arginine-rich splicing factor 3 (SRSF3) could directly bind to CCDC50-S mRNA to maintain its stability in the cytoplasm, which enhanced oncogenic progression of hepatocellular carcinoma through the Ras/Foxo4 signaling pathway [17].